Microneedles for Trans and Intradermal Drug Delivery-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Microneedles for Trans and Intradermal Drug Delivery-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Microneedles for Trans and Intradermal Drug Delivery industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Microneedles for Trans and Intradermal Drug Delivery 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Microneedles for Trans and Intradermal Drug Delivery worldwide and market share by regions, with company and product introduction, position in the Microneedles for Trans and Intradermal Drug Delivery market
Market status and development trend of Microneedles for Trans and Intradermal Drug Delivery by types and applications
Cost and profit status of Microneedles for Trans and Intradermal Drug Delivery, and marketing status
Market growth drivers and challenges
The report segments the global Microneedles for Trans and Intradermal Drug Delivery market as:
Global Microneedles for Trans and Intradermal Drug Delivery Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Microneedles for Trans and Intradermal Drug Delivery Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Global Microneedles for Trans and Intradermal Drug Delivery Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Drugs
Vaccines
Proteins
Peptides
Others
Global Microneedles for Trans and Intradermal Drug Delivery Market: Manufacturers Segment Analysis (Company and Product introduction, Microneedles for Trans and Intradermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin):
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Microneedles for Trans and Intradermal Drug Delivery-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Microneedles for Trans and Intradermal Drug Delivery industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Microneedles for Trans and Intradermal Drug Delivery 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Microneedles for Trans and Intradermal Drug Delivery worldwide and market share by regions, with company and product introduction, position in the Microneedles for Trans and Intradermal Drug Delivery market
Market status and development trend of Microneedles for Trans and Intradermal Drug Delivery by types and applications
Cost and profit status of Microneedles for Trans and Intradermal Drug Delivery, and marketing status
Market growth drivers and challenges
The report segments the global Microneedles for Trans and Intradermal Drug Delivery market as:
Global Microneedles for Trans and Intradermal Drug Delivery Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Microneedles for Trans and Intradermal Drug Delivery Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Global Microneedles for Trans and Intradermal Drug Delivery Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Drugs
Vaccines
Proteins
Peptides
Others
Global Microneedles for Trans and Intradermal Drug Delivery Market: Manufacturers Segment Analysis (Company and Product introduction, Microneedles for Trans and Intradermal Drug Delivery Sales Volume, Revenue, Price and Gross Margin):
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
1.1 Definition of Microneedles for Trans and Intradermal Drug Delivery in This Report
1.2 Commercial Types of Microneedles for Trans and Intradermal Drug Delivery
1.2.1 Solid Microneedles
1.2.2 Hollow Microneedles
1.2.3 Dissolvable Microneedles
1.3 Downstream Application of Microneedles for Trans and Intradermal Drug Delivery
1.3.1 Drugs
1.3.2 Vaccines
1.3.3 Proteins
1.3.4 Peptides
1.3.5 Others
1.4 Development History of Microneedles for Trans and Intradermal Drug Delivery
1.5 Market Status and Trend of Microneedles for Trans and Intradermal Drug Delivery 2013-2023
1.5.1 Global Microneedles for Trans and Intradermal Drug Delivery Market Status and Trend 2013-2023
1.5.2 Regional Microneedles for Trans and Intradermal Drug Delivery Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Microneedles for Trans and Intradermal Drug Delivery 2013-2017
2.2 Sales Market of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.2.1 Sales Volume of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.2.2 Sales Value of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.3 Production Market of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.4 Global Market Forecast of Microneedles for Trans and Intradermal Drug Delivery 2018-2023
2.4.1 Global Market Forecast of Microneedles for Trans and Intradermal Drug Delivery 2018-2023
2.4.2 Market Forecast of Microneedles for Trans and Intradermal Drug Delivery by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Microneedles for Trans and Intradermal Drug Delivery by Types
3.2 Sales Value of Microneedles for Trans and Intradermal Drug Delivery by Types
3.3 Market Forecast of Microneedles for Trans and Intradermal Drug Delivery by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Microneedles for Trans and Intradermal Drug Delivery by Downstream Industry
4.2 Global Market Forecast of Microneedles for Trans and Intradermal Drug Delivery by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
5.1.1 North America Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
5.1.2 North America Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
5.1.3 United States Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
5.1.4 Canada Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
5.1.5 Mexico Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
5.2 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
5.3 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
5.3.1 North America Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
5.3.2 North America Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
5.4 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
6.1.1 Europe Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
6.1.2 Europe Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
6.1.3 Germany Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.4 UK Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.5 France Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.6 Italy Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.7 Russia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.8 Spain Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.9 Benelux Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.2 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
6.3 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
6.3.1 Europe Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
6.3.2 Europe Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
6.4 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
7.1.1 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
7.1.2 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
7.1.3 China Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.4 Japan Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.5 India Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.6 Southeast Asia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.7 Australia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.2 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
7.3 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
7.3.1 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
7.3.2 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
7.4 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
8.1.1 Latin America Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
8.1.2 Latin America Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
8.1.3 Brazil Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
8.1.4 Argentina Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
8.1.5 Colombia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
8.2 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
8.3 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
8.3.1 Latin America Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
8.3.2 Latin America Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
8.4 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
9.1.1 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
9.1.3 Middle East Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
9.1.4 Africa Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
9.2 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
9.3 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
9.3.2 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
9.4 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
10.1 Global Economy Situation and Trend Overview
10.2 Microneedles for Trans and Intradermal Drug Delivery Downstream Industry Situation and Trend Overview
CHAPTER 11 MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Microneedles for Trans and Intradermal Drug Delivery by Major Manufacturers
11.2 Production Value of Microneedles for Trans and Intradermal Drug Delivery by Major Manufacturers
11.3 Basic Information of Microneedles for Trans and Intradermal Drug Delivery by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Microneedles for Trans and Intradermal Drug Delivery Major Manufacturer
11.3.2 Employees and Revenue Level of Microneedles for Trans and Intradermal Drug Delivery Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Becton Dickinson
12.1.1 Company profile
12.1.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.1.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Becton Dickinson
12.2 Nanopass Technologies
12.2.1 Company profile
12.2.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.2.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Nanopass Technologies
12.3 Radius Health
12.3.1 Company profile
12.3.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.3.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Radius Health
12.4 Clearside Biomedical
12.4.1 Company profile
12.4.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.4.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Clearside Biomedical
12.5 Dr. Prausnitz Group
12.5.1 Company profile
12.5.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.5.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Dr. Prausnitz Group
12.6 Zosano Pharma
12.6.1 Company profile
12.6.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.6.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Zosano Pharma
12.7 Corium International
12.7.1 Company profile
12.7.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.7.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Corium International
12.8 Circassia
12.8.1 Company profile
12.8.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.8.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Circassia
12.9 Valeritas, Inc.
12.9.1 Company profile
12.9.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.9.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Valeritas, Inc.
12.10 BD Medical
12.10.1 Company profile
12.10.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.10.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of BD Medical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
13.1 Industry Chain of Microneedles for Trans and Intradermal Drug Delivery
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
14.1 Cost Structure Analysis of Microneedles for Trans and Intradermal Drug Delivery
14.2 Raw Materials Cost Analysis of Microneedles for Trans and Intradermal Drug Delivery
14.3 Labor Cost Analysis of Microneedles for Trans and Intradermal Drug Delivery
14.4 Manufacturing Expenses Analysis of Microneedles for Trans and Intradermal Drug Delivery
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Microneedles for Trans and Intradermal Drug Delivery in This Report
1.2 Commercial Types of Microneedles for Trans and Intradermal Drug Delivery
1.2.1 Solid Microneedles
1.2.2 Hollow Microneedles
1.2.3 Dissolvable Microneedles
1.3 Downstream Application of Microneedles for Trans and Intradermal Drug Delivery
1.3.1 Drugs
1.3.2 Vaccines
1.3.3 Proteins
1.3.4 Peptides
1.3.5 Others
1.4 Development History of Microneedles for Trans and Intradermal Drug Delivery
1.5 Market Status and Trend of Microneedles for Trans and Intradermal Drug Delivery 2013-2023
1.5.1 Global Microneedles for Trans and Intradermal Drug Delivery Market Status and Trend 2013-2023
1.5.2 Regional Microneedles for Trans and Intradermal Drug Delivery Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Microneedles for Trans and Intradermal Drug Delivery 2013-2017
2.2 Sales Market of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.2.1 Sales Volume of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.2.2 Sales Value of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.3 Production Market of Microneedles for Trans and Intradermal Drug Delivery by Regions
2.4 Global Market Forecast of Microneedles for Trans and Intradermal Drug Delivery 2018-2023
2.4.1 Global Market Forecast of Microneedles for Trans and Intradermal Drug Delivery 2018-2023
2.4.2 Market Forecast of Microneedles for Trans and Intradermal Drug Delivery by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Microneedles for Trans and Intradermal Drug Delivery by Types
3.2 Sales Value of Microneedles for Trans and Intradermal Drug Delivery by Types
3.3 Market Forecast of Microneedles for Trans and Intradermal Drug Delivery by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Microneedles for Trans and Intradermal Drug Delivery by Downstream Industry
4.2 Global Market Forecast of Microneedles for Trans and Intradermal Drug Delivery by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
5.1.1 North America Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
5.1.2 North America Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
5.1.3 United States Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
5.1.4 Canada Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
5.1.5 Mexico Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
5.2 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
5.3 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
5.3.1 North America Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
5.3.2 North America Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
5.4 North America Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
6.1.1 Europe Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
6.1.2 Europe Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
6.1.3 Germany Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.4 UK Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.5 France Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.6 Italy Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.7 Russia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.8 Spain Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.1.9 Benelux Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
6.2 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
6.3 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
6.3.1 Europe Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
6.3.2 Europe Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
6.4 Europe Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
7.1.1 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
7.1.2 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
7.1.3 China Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.4 Japan Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.5 India Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.6 Southeast Asia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.1.7 Australia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
7.2 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
7.3 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
7.3.1 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
7.3.2 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
7.4 Asia Pacific Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
8.1.1 Latin America Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
8.1.2 Latin America Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
8.1.3 Brazil Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
8.1.4 Argentina Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
8.1.5 Colombia Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
8.2 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
8.3 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
8.3.1 Latin America Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
8.3.2 Latin America Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
8.4 Latin America Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Countries
9.1.1 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Revenue by Countries (2013-2017)
9.1.3 Middle East Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
9.1.4 Africa Microneedles for Trans and Intradermal Drug Delivery Market Status (2013-2017)
9.2 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Manufacturers
9.3 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Sales by Type (2013-2017)
9.3.2 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Revenue by Type (2013-2017)
9.4 Middle East and Africa Microneedles for Trans and Intradermal Drug Delivery Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
10.1 Global Economy Situation and Trend Overview
10.2 Microneedles for Trans and Intradermal Drug Delivery Downstream Industry Situation and Trend Overview
CHAPTER 11 MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Microneedles for Trans and Intradermal Drug Delivery by Major Manufacturers
11.2 Production Value of Microneedles for Trans and Intradermal Drug Delivery by Major Manufacturers
11.3 Basic Information of Microneedles for Trans and Intradermal Drug Delivery by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Microneedles for Trans and Intradermal Drug Delivery Major Manufacturer
11.3.2 Employees and Revenue Level of Microneedles for Trans and Intradermal Drug Delivery Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Becton Dickinson
12.1.1 Company profile
12.1.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.1.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Becton Dickinson
12.2 Nanopass Technologies
12.2.1 Company profile
12.2.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.2.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Nanopass Technologies
12.3 Radius Health
12.3.1 Company profile
12.3.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.3.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Radius Health
12.4 Clearside Biomedical
12.4.1 Company profile
12.4.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.4.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Clearside Biomedical
12.5 Dr. Prausnitz Group
12.5.1 Company profile
12.5.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.5.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Dr. Prausnitz Group
12.6 Zosano Pharma
12.6.1 Company profile
12.6.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.6.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Zosano Pharma
12.7 Corium International
12.7.1 Company profile
12.7.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.7.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Corium International
12.8 Circassia
12.8.1 Company profile
12.8.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.8.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Circassia
12.9 Valeritas, Inc.
12.9.1 Company profile
12.9.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.9.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of Valeritas, Inc.
12.10 BD Medical
12.10.1 Company profile
12.10.2 Representative Microneedles for Trans and Intradermal Drug Delivery Product
12.10.3 Microneedles for Trans and Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin of BD Medical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
13.1 Industry Chain of Microneedles for Trans and Intradermal Drug Delivery
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MICRONEEDLES FOR TRANS AND INTRADERMAL DRUG DELIVERY
14.1 Cost Structure Analysis of Microneedles for Trans and Intradermal Drug Delivery
14.2 Raw Materials Cost Analysis of Microneedles for Trans and Intradermal Drug Delivery
14.3 Labor Cost Analysis of Microneedles for Trans and Intradermal Drug Delivery
14.4 Manufacturing Expenses Analysis of Microneedles for Trans and Intradermal Drug Delivery
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
